eIF2B Modulator Synthesis Using Crystalline Salt Intermediates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing small molecule modulators of eukaryotic initiation factor 2B (eIF2B) face challenges such as malodorous reactions and difficulties in purification due to the use of oils or liquid forms, which complicates handling and processing.

Innovation Solution

Improved processes for synthesizing small molecule modulators of eIF2B that avoid malodorous reactions and produce stable, crystalline salt forms, facilitating easier purification and handling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional synthesis methods are used to prepare eIF2B modulators, then the compounds can be synthesized, but malodorous reactions and difficulties in purification occur due to the use of oils or liquid forms

Engineering Contradiction:
Improveease of purificationVSAvoidmalodorous reactions
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent changes the physical state parameter of the product from liquid/oil form to solid crystalline salt form. This phase change eliminates the malodorous reactions and purification difficulties associated with liquid forms, while maintaining the chemical identity and therapeutic activity of the eIF2B modulators.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the harmful malodorous reactions and difficult purification processes into beneficial crystalline salt forms. By forming crystalline salts, the previously harmful liquid-phase reactions are transformed into clean, odorless solid-state products that are easily purified and handled.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Ease of operation

If oils or liquid forms are used in the synthesis process, then the compounds can be formed, but the subsequent purification process and handling become difficult

Engineering Contradiction:
Improveease of handlingVSAvoidcomplexity of purification process
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent changes the physical state from liquid to solid crystalline form, which fundamentally improves handling characteristics. Solid crystalline salts are easier to manipulate, store, and purify compared to oils or liquid forms, directly reducing the complexity of purification processes.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes phase transition from liquid/oil to solid crystalline state to simplify the synthesis and purification process. This phase change enables the formation of stable crystalline salts that can be easily separated and purified through standard solid-state techniques, eliminating the need for complex liquid-phase purification methods.

Inventive Principle:
Principle #36Phase transitions

Data Source

PatentUS20250376432A1Process for preparing modulators of eukaryotic initiation factor 2b
Publication Date: 2025.12.11 DENALI THERAPEUTICS INC
  • US20250376432A1 patent drawing
  • US20250376432A1 patent drawing
  • US20250376432A1 patent drawing

AI summary

The present disclosure relates generally to methods for the preparation of Compound (I-1): I-1 or a stereoisomer or mixture of stereoisomers thereof, or salt of each thereof, as well as compounds and salts which are useful in the synthesis thereof.